Retatrutide
A 10mg presentation of the GLP-1/GIP/glucagon triple agonist retatrutide, ideal for pilot studies and shorter dose-ranging protocols where a lower per-vial quantity is preferred.
Sold for laboratory research use only. Not for human or animal consumption.
- Verified purity
- 99.3%
- Dose per vial
- 10mg
- Molecular weight
- 4731.3 g/mol
- Sequence
- 39-residue synthetic peptide
- CAS number
- 2381089-83-2
- Form
- Lyophilized powder
- Storage
- -20°C, protect from light
Research applications.
Triple-agonist metabolic research in a starter concentration.
- 01
Pilot-scale GLP-1 / GIP / glucagon agonism studies
- 02
Receptor-binding affinity characterization
- 03
Metabolic-rate and energy-balance research models
- 04
Short-duration dose-ranging protocols
This product is sold strictly for laboratory research purposes. It is not intended for human or animal consumption and has not been approved by the FDA. You must be 21 or older and a qualified researcher to purchase.
Related compounds.
Back to all products
Retatrutide
Triple-agonist metabolic research at full research strength.
MOTS-c
Mitochondrial-derived peptide for metabolic and longevity research.
